✦ LIBER ✦

Glycogen synthase kinase-3—a new target for lithium's effects in bipolar patients?

✍ Scribed by Galila Agam; Joseph Levine

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 90 KB
Volume: 13
Category: Article
ISSN: 0885-6222
DOI: 10.1002/(sici)1099-1077(1998100)13:7<463::aid-hup28>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glycogen synthase kinase-3β, β-catenin,

Glycogen synthase kinase-3β, β-catenin, and tau in postmortem bipolar brain

✍ M. Lesort; A. Greendorfer; C. Stockmeier; G. V. W. Johnson; R. S. Jope 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 118 KB

The first synthesis of [11C]SB-216763, a

The first synthesis of [11C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3)

✍ Min Wang; Mingzhang Gao; Kathy D. Miller; George W. Sledge; Gary D. Hutchins; Qi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 464 KB

synthase kinase-3 (GSK-3) Radiosynthesis Positron emission tomography (PET) Cancer Alzheimer's disease a b s t r a c t SB-216763 is a novel, potent and selective glycogen synthase kinase-3 (GSK-3) inhibitor with an IC 50 value of 34 nM. , a new potential PET agent for imaging of GSK-3, was first de

Glucocorticoid-induced insulin resistanc

Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor

✍ J. Ruzzin; A. S. Wagman; J. Jensen 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 479 KB

Chromosomal mapping and mutational analy

Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3α and β isoforms in patients with NIDDM

✍ L. Hansen; K. C. Arden; S. B. Rasmussen; C. S. Viars; H. Vestergaard; T. Hansen; 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 337 KB